The Emerging Role of Nutrition in Parkinson's Disease

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2014 Mar 19

PMID 24639650

Citations 82

Authors

Stacey E Seidl

Jose A Santiago

Hope Bilyk

Judith A Potashkin

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD) is the second most prevalent neurodegenerative disease in ageing individuals. It is now clear that genetic susceptibility and environmental factors play a role in disease etiology and progression. Because environmental factors are involved with the majority of the cases of PD, it is important to understand the role nutrition plays in both neuroprotection and neurodegeneration. Recent epidemiological studies have revealed the promise of some nutrients in reducing the risk of PD. In contrast, other nutrients may be involved with the etiology of neurodegeneration or exacerbate disease progression. This review summarizes the studies that have addressed these issues and describes in detail the nutrients and their putative mechanisms of action in PD.

Citing Articles

Postmortem Fatty Acid Abnormalities in the Cerebellum of Patients with Essential Tremor.

Simard M, Melancon K, Berthiaume L, Tremblay C, Pshevorskiy L, Julien P Cerebellum. 2024; 23(6):2341-2359.

PMID: 39215908 PMC: 11585516. DOI: 10.1007/s12311-024-01736-4.

Mediterranean Diet Adherence, Gut Microbiota and Parkinson's Disease: A Systematic Review.

Seelarbokus B, Menozzi E, Schapira A, Kalea A, Macnaughtan J Nutrients. 2024; 16(14).

PMID: 39064625 PMC: 11280252. DOI: 10.3390/nu16142181.

Effects of dietary supplements, foods, and dietary patterns in Parkinson's disease: meta-analysis and systematic review of randomized and crossover studies.

Wu L, Chu L, Pang Y, Huo J, Cao H, Tian Q Eur J Clin Nutr. 2024; 78(5):365-375.

PMID: 38378765 DOI: 10.1038/s41430-024-01411-1.

Exploring the complexities of 1C metabolism: implications in aging and neurodegenerative diseases.

Bou Ghanem A, Hussayni Y, Kadbey R, Ratel Y, Yehya S, Khouzami L Front Aging Neurosci. 2024; 15:1322419.

PMID: 38239489 PMC: 10794399. DOI: 10.3389/fnagi.2023.1322419.

Advancing nutrition science to meet evolving global health needs.

Neufeld L, Ho E, Obeid R, Tzoulis C, Green M, Huber L Eur J Nutr. 2023; 62(Suppl 1):1-16.

PMID: 38015211 PMC: 10684707. DOI: 10.1007/s00394-023-03276-9.

References

Fall P, Fredrikson M, Axelson O, Granerus A . Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord. 1999; 14(1):28-37. DOI: 10.1002/1531-8257(199901)14:1<28::aid-mds1007>3.0.co;2-o. View

Anandhan A, Tamilselvam K, Radhiga T, Rao S, Essa M, Manivasagam T . Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease. Brain Res. 2011; 1433:104-13. DOI: 10.1016/j.brainres.2011.11.021. View

Aneja R, Odoms K, Denenberg A, Wong H . Theaflavin, a black tea extract, is a novel anti-inflammatory compound. Crit Care Med. 2004; 32(10):2097-103. DOI: 10.1097/01.ccm.0000142661.73633.15. View

Chen J, Xu K, Petzer J, Staal R, Xu Y, Beilstein M . Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci. 2001; 21(10):RC143. PMC: 6762498. View

Simopoulos A . Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999; 70(3 Suppl):560S-569S. DOI: 10.1093/ajcn/70.3.560s. View

Kim J, Kim J, O J, Jeon B . Inhibition of inducible nitric oxide synthase expression and cell death by (-)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Clin Neurosci. 2010; 17(9):1165-8. DOI: 10.1016/j.jocn.2010.01.042. View

Smith M, Fletcher-Turner A, Yurek D, Cass W . Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem Res. 2006; 31(4):533-9. DOI: 10.1007/s11064-006-9048-4. View

Bureau G, Longpre F, Martinoli M . Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J Neurosci Res. 2007; 86(2):403-10. DOI: 10.1002/jnr.21503. View

Altman R, Lang A, Postuma R . Caffeine in Parkinson's disease: a pilot open-label, dose-escalation study. Mov Disord. 2011; 26(13):2427-31. DOI: 10.1002/mds.23873. View

10.

Kim S, Lee M, Hong J, Li C, Smith T, Yang G . Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer. 2000; 37(1):41-8. DOI: 10.1207/S15327914NC3701_5. View

11.

Nakaso K, Ito S, Nakashima K . Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells. Neurosci Lett. 2008; 432(2):146-50. DOI: 10.1016/j.neulet.2007.12.034. View

12.

Shults C, Beal M, Song D, Fontaine D . Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Exp Neurol. 2004; 188(2):491-4. DOI: 10.1016/j.expneurol.2004.05.003. View

13.

Chen H, OReilly E, McCullough M, Rodriguez C, Schwarzschild M, Calle E . Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiol. 2007; 165(9):998-1006. PMC: 2232901. DOI: 10.1093/aje/kwk089. View

14.

Gao X, Chen H, Choi H, Curhan G, Schwarzschild M, Ascherio A . Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol. 2008; 167(7):831-8. PMC: 2367211. DOI: 10.1093/aje/kwm385. View

15.

Samadi P, Gregoire L, Rouillard C, Bedard P, Di Paolo T, Levesque D . Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Ann Neurol. 2006; 59(2):282-8. DOI: 10.1002/ana.20738. View

16.

Sato Y, Kikuyama M, Oizumi K . High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology. 1997; 49(5):1273-8. DOI: 10.1212/wnl.49.5.1273. View

17.

Chan C, Gertler T, Surmeier D . Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci. 2009; 32(5):249-56. PMC: 4831702. DOI: 10.1016/j.tins.2009.01.006. View

18.

Baluchnejadmojarad T, Roghani M, Jalali Nadoushan M, Bagheri M . Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model. Phytother Res. 2008; 23(1):132-5. DOI: 10.1002/ptr.2564. View

19.

Xu K, Xu Y, Chen J, Schwarzschild M . Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice. Neurosci Lett. 2002; 322(1):13-6. DOI: 10.1016/s0304-3940(02)00069-1. View

20.

Leaver K, Allbutt H, Creber N, Kassiou M, Henderson J . Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotection. Brain Res Bull. 2009; 80(6):397-402. DOI: 10.1016/j.brainresbull.2009.08.013. View